Kuros Biosciences Gets FDA’s 510(k) Clearance for Surgical Putty

September 10, 2021

Swiss bone graft technology company Kuros Biosciences has received the FDA’s 510(k) clearance for its MagnetOs Easypack putty for placing into gaps in the skeletal system, particularly the posterolateral spine.

A soft and moldable formulation for use during spinal fusion surgery, the putty can be stored at room temperature and can be used immediately from the packaging, with no need for mixing with blood or bone marrow, the company said.

The MagnetOs putty is broken down by the body and replaced with bone during the healing process.

Zurich, Switzerland-based Kuros previously received 510(k) marketing clearances from the FDA for its MagnetOs granules and putty. 

View today's stories